Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Not Confirmed
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Not Confirmed
Not Confirmed
21-22 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Pharmtech & Ingredient...Pharmtech & Ingredients
Industry Trade Show
Not Confirmed
19-22 November, 2024
Rescon USA SummitRescon USA Summit
Industry Trade Show
Not Confirmed
21-22 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
13 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/13/2980105/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-Third-Quarter-2024.html
12 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/12/2979662/0/en/Fulcrum-Therapeutics-to-Participate-in-the-Stifel-Healthcare-Conference.html
06 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/06/2975639/0/en/Fulcrum-Therapeutics-to-Host-Third-Quarter-2024-Financial-Results-Conference-Call-and-Webcast-on-Wednesday-November-13-2024-at-8-00-a-m-ET.html
11 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/11/2962200/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
13 Sep 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/fulcrums-muscle-disorder-drug-fails-late-stage-study-2024-09-12/
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2946162/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?